Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference
September 03 2019 - 6:59AM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) will take part in a
fireside chat at the Morgan Stanley Conference on Monday, September
9, 2019, in New York. Giovanni Caforio, M.D., chairman and chief
executive officer will answer questions at 4:15 p.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190903005003/en/
Media: Carrie
Fernandez, 609-252-5222, carrie.fernandez@bms.com
Investors: Tim Power,
609-252-7509, timothy.power@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024